ADIPOQ and type 2 diabetes mellitus: It found that the factors increasing the likelihood of having MCI in elderly patients with type 2 diabetes were fewer years of formal education, the presence of previous CVD and hypertension, increased number of co-morbidities, poorer glycaemic control (higher HbA1c level), higher levels of IL-1 β and lower level of adiponectin.